Please use this identifier to cite or link to this item: https://scholarbank.nus.edu.sg/handle/10635/137643
Title: QUANTITATIVE BIOFLUID ENZYME ACTIVITY ASSAY AND SINGLE CELL ANALYSIS FOR PRECISION MEDICINE VIA INTEGRATED MICROFLUIDICS
Authors: NG EE XIEN
ORCID iD:   orcid.org/0000-0003-2833-4427
Keywords: Droplet microfluidics, protease assay, FRET sensors, single cell analysis, precision medicine, bioengineering
Issue Date: 27-Jul-2017
Citation: NG EE XIEN (2017-07-27). QUANTITATIVE BIOFLUID ENZYME ACTIVITY ASSAY AND SINGLE CELL ANALYSIS FOR PRECISION MEDICINE VIA INTEGRATED MICROFLUIDICS. ScholarBank@NUS Repository.
Abstract: In the context of precision medicine, the capability of diagnostic and screening tools to obtain large amount of personalized measurement from individual patient at small sample volume is crucial. In this dissertation, several droplet-based microfluidics platforms have been developed to screen cancer samples of both liquid and solid state for multiplexed analysis all while using small sample volume. A novel computational analysis method, Proteolytic Activity Matrix Analysis (PrAMA), was integrated to perform multiplexed analysis on a family of cancer-related proteases known as metalloproteinases (MPs) including matrix metalloproteinases (MMPs) and a disintegrin and metalloproteinases (ADAMs). With the development of these microfluidic platforms as well as the research findings of utilizing metalloproteinases as potential biomarker for cancer, this work aims to provide a patient-specific approach for cancer screening and disease monitoring, thus taking one step closer to achieving “precision medicine”.
URI: http://scholarbank.nus.edu.sg/handle/10635/137643
Appears in Collections:Ph.D Theses (Open)

Show full item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
NgEX.pdf4.84 MBAdobe PDF

OPEN

NoneView/Download

Page view(s)

138
checked on Jul 10, 2020

Download(s)

1
checked on Jul 10, 2020

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.